Article
In Vitro Evaluation of the Potential Synergistic Interactions Between Apigenin and Bortezomib in U266 Multiple Myeloma Cells
2026-02-10
Abstract excerpt
<title>Abstract</title> <p>Purpose This study aimed to evaluate the cytotoxic, apoptotic, and cell cycle regulatory effects of the combination of Apigenin, a natural flavonoid, and the proteasome inhibitor Bortezomib on U266 multiple myeloma cells, and to quantify the potential synergistic interaction. Methods U266 cells were treated with different doses of Bortezomib and Apigenin at 24, 48, and 72 hours of inc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 16f0c5c4-f423-5bcb-9806-d763394d7477
- DOI
- 10.21203/rs.3.rs-8311130/v1
